Edwards Lifesciences Corporation Share Price
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
21:00:03 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 89.90 USD | +0.13% |
|
-0.34% | +5.45% |
| Market Cap | 51.82B 44.63B 41.92B 38.32B 71.7B 4,896B 71.95B 496B 192B 2,509B 195B 190B 8,095B | P/E 2026 * |
35.5x | P/E 2027 * | 27.2x |
|---|---|---|---|---|---|
| Enterprise Value | 48.19B 41.5B 38.98B 35.64B 66.68B 4,553B 66.91B 461B 179B 2,333B 181B 177B 7,528B | EV / Sales 2026 * |
7.13x | EV / Sales 2027 * | 6.28x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Tradegate
| EWL | Real-time | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Xetra
| EWL | Delayed | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript : Edwards Lifesciences Corporation
| 1 day | +0.13% | ||
| 1 week | -0.34% | ||
| Current month | -0.94% | ||
| 1 month | +1.05% | ||
| 3 months | +4.58% | ||
| 6 months | +7.16% | ||
| Current year | +5.45% |
| 1 week | 88.4 |  | 92.95 |
| 1 month | 88.4 | | 93.91 |
| Current year | 74.66 | | 96.29 |
| 1 year | 72.3 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 10/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 28/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 31/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 06/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 09/02/2015 |
| Director/Board Member | 58 | 10/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/08/26 | Sell | Controller/Auditor | -544 | 0.0001% | ||
| 28/08/26 | Sell | Executive/Senior Manager | -2,644 | 0.0005% | ||
| 26/08/26 | Sell | Executive/Senior Manager | -1,240 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | -0.34% | +11.07% | +18.34% | 51.82B | |
| -0.75% | -1.35% | +24.60% | +13.24% | 227B | |
| -1.60% | -3.89% | +3.72% | -20.39% | 146B | |
| -0.85% | -1.58% | -21.45% | +19.18% | 130B | |
| +1.81% | +2.05% | -55.42% | -10.32% | 69.27B | |
| +0.49% | -1.32% | -17.27% | -14.42% | 50.45B | |
| +0.59% | -1.94% | +17.17% | +27.06% | 42.53B | |
| -1.01% | -1.28% | +33.64% | +48.14% | 40.22B | |
| -1.55% | +1.22% | +120.58% | +36.88% | 32.95B | |
| -0.37% | -4.98% | -17.58% | +48.39% | 32.94B | |
| Average | -0.31% | -1.77% | +9.91% | +16.61% | 82.27B | |
| Weighted average by Cap. | -0.53% | -2.04% | +5.70% | +9.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 5.82B 5.47B 5B 9.35B 639B 9.39B 64.65B 25.06B 327B 25.38B 24.83B 1,056B | 7.43B 6.4B 6.01B 5.49B 10.28B 702B 10.32B 71.05B 27.55B 360B 27.89B 27.29B 1,161B |
| Net income | 1.44B 1.24B 1.16B 1.06B 1.99B 136B 1.99B 13.73B 5.32B 69.5B 5.39B 5.27B 224B | 1.9B 1.63B 1.53B 1.4B 2.62B 179B 2.63B 18.14B 7.03B 91.85B 7.12B 6.97B 296B |
| Net Debt | -3.63B -3.13B -2.94B -2.69B -5.02B -343B -5.04B -34.73B -13.46B -176B -13.63B -13.34B -567B | -5.19B -4.47B -4.2B -3.84B -7.19B -491B -7.21B -49.68B -19.26B -252B -19.5B -19.08B -812B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | US$89.90 | +0.13% | 2,635,295 |
| 03/09/26 | US$89.78 | -1.15% | 1,844,143 |
| 02/09/26 | US$90.82 | +0.09% | 2,595,780 |
| 01/09/26 | US$90.74 | -0.01% | 2,539,929 |
| 31/08/26 | US$90.75 | +0.60% | 4,047,531 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
